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Background: In the UK, the recruitment of patients into clinical research is a national health research and development
policy priority. There has been limited investigation of how national level factors operate as barriers or facilitators to
recruitment work, particularly from the perspective of staff undertaking patient recruitment work. The aim of this study is
to identify and examine staff views of the key organisational barriers and facilitators to patient recruitment work in one
clinical research group located in an NHS Academic Health Science Centre.
Methods: A qualitative study utilizing in-depth, one-to-one semi-structured interviews with 11 purposively
selected staff with particular responsibilities to recruit and retain patients as clinical research subjects. Thematic
analysis classified interview data by recurring themes, concepts, and emergent categories for the purposes of
establishing explanatory accounts.
Results: The findings highlight four key factors that staff perceived to be most significant for the successful
recruitment and retention of patients in research and identify how staff located these factors within patients,
studies, the research centre, the trust, and beyond the trust. Firstly, competition for research participants at an
organisational and national level was perceived to undermine recruitment success. Secondly, the tension
between clinical and clinical research workloads was seen to interrupt patient recruitment into studies, despite
national funding arrangements to manage excess treatment costs. Thirdly, staff perceived an imbalance between
personal patient burden and benefit. Ethical committee regulation, designed to protect patients, was perceived
by some staff to detract from clarification and systematisation of incentivisation strategies. Finally, the structure
and relationships within clinical research teams, in particular the low tacit status of recruitment skills, was seen as
influential.
Conclusions: The results of this case-study, conducted in an exemplary NHS academic research centre, highlight
current systematic challenges to patient recruitment and retention in clinical studies more generally as seen from
the perspective of staff at the ‘sharp end’ of recruiting. Staff experience is that, beyond individual clinical research
design and protocol factors, wider organisational and extra-organisational norms, structures, and processes operate as
significant facilitators or hindrances in the recruitment of patients as research subjects.
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Given recent UK national policy directives encouraging
a ‘research embedded National Health Service (NHS)’
[1], biomedical research is an important organisational
priority for all NHS organisations. In addition, a key rec-
ommendation of the government’s Life Science Strategy
is for health care organisations to respond to “the grow-
ing readiness of patients to participate in research” and
to provide adequate infra-structural support to re-
searchers to respond to patient interest and choice with
respect to research participation [2]. Nevertheless, there
is extensive research evidence from the NHS acute hos-
pital sector that poor patient recruitment or retention of
patients to clinical research is widespread, leading to de-
lays in the start or completion of both academic and
commercially funded research, the reduced external val-
idity of studies, and wasted public resources and oppor-
tunity for patient participation [3-6].
Studies examining the factors that support or detract
from the successful recruitment and retention of patients
into clinical studies tend to focus on the influence of one
or more of the following three interconnected factors.
First, procedural issues; research suggests that methods
of patient recruitment into individual or into a series of
research studies can influence recruitment [3,7]. This
includes the finding that business models to promote
research participation can aid recruitment [7,8]. In addition,
more successful recruitment rates and higher positive
research awareness have been associated with multi-
disciplinary teams’ involvement in recruitment [6] and with
wider stakeholder involvement in research design and
processes [6,9].
Second, communication and perceptual issues; how
the immediate and longer-term value of clinical studies
[5,10,11], as well as specific outcomes of a study [12],
are perceived by and communicated to research partici-
pants, other patients, the public, and the clinical and
clinical-research communities. Patients’ perceptions of
the harm or benefit of studies have been found to be
influential [13,14], as have their treatment preferences
[14-16]. However, the literature suggests that these per-
ceptions do not exist in isolation. Rather, the quality of a
clinical relationship or encounter is noted as significant
for engaging patients as research subjects [17,18] and for
retaining them as such [19]. It has been found that pa-
tients’ acceptance of equipoise can be unintentionally in-
fluenced by how the research is communicated to them
[18,20,21]. In addition, participation can be influenced
by the ability of recruiters to explain complex trials
[22-24]. More broadly, studies have asserted the need for
improved public and patient awareness of clinical re-
search [5,6,25] and clinical research outcomes in general
[12]. The ‘public and patient participation’ approach is
recently echoed in National Institute of Health Research(NIHR) policy initiatives [26] – where it is anticipated
that the more patients ask about research, the more
NHS staff will become involved in research – and in
directives from the Association of Medical Research
Charities [27], which notes the recruitment potential of
patients’ self-referring into studies and bypassing their
own clinicians.
This self-referral approach is based also on the finding
that patients themselves are not the only gatekeepers to
recruitment. The influence of clinical and non-clinical
‘gate keepers’ within clinical services has also been iden-
tified [5,25,28-30] and the literature emphasises the im-
pact of communication of the research to recruiters. In a
systematic review of the literature, Ross et al. [15] found
that clinicians’ perceptions of the importance of the re-
search question impacts recruitment. Similarly, it has
been found that recruiter perceptions of potential harm
or benefit to patients are important [5]. Research has
further explored the potential for recruiters to be less
willing to approach potential participants due to re-
cruiter misunderstandings regarding aspects of the trial
[14,22,31,32].
Third, resourcing issues; how national and organisa-
tional incentivisation strategies stymie recruitment work
within, and between, individual studies. Proposed strat-
egies to enhance this work include reducing clinicians’
clinical workload [5] and incentivisation of clinical staff
without clinical research remits, for example, the provision
of protected time, training, or career progression oppor-
tunities [5,7,25,33]. In addition, several studies highlight
the advantages of investment in cross-project, cross-
service, or cross-organisational recruitment databases or
‘gate ways’ for sustaining pools of potential research
subjects [34,35].
Despite this extensive literature on strategies for
enhancing patient recruitment to research, gaps remain.
The current literature base rightly emphasizes the suc-
cess of national, systematic initiatives, including the
NIHR, Clinical Research Network, to improve recruit-
ment [36,37]. However, to the authors’ knowledge, the
literature has not, to date, assessed whether factors at
the national or systemic level can simultaneously and
unintentionally present barriers to recruitment in par-
ticular research contexts. In addition, the influence of
organisational context on recruitment, as well as the
importance of understanding recruiters’ perceptions, has
increasingly been recognised. More recently, the value of
qualitative studies has been highlighted with a view to
addressing these concerns [5,7,8,21,22,38]. In particular,
Fletcher et al. [5] briefly draw from established organisa-
tional sociology concepts and models to examine the
variously levelled reasons for poor patient recruitment at
patient, recruiting clinician, trial design, trial centre, and
organisational levels. Therefore, despite the extensive
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to research, there remains a lack of substantive, high
quality research evidence of the actual activities and ex-
periences of patient recruitment work [5,8,38] and of the
impact of organisational strategies on this work. More-
over, as Gul and Abi [39] note, the majority of recom-
mended interventions for enhancing the recruitment
and retention of patients in clinical studies are ‘piece-
meal’ (for example, the improvement of patient informa-
tion resources) and take little account of how local
cultures and practices of recruitment work influence the
effectiveness of such interventions. In other words, it is
unclear how, and how far, the different sets of issues that
support or undermine patient recruitment into research
are interconnected in general and specific clinical
settings, research teams, and research centres.
In order to contribute to filling these gaps in the litera-
ture, this study sought to explore perceived barriers and
facilitators to patient recruitment and retention to
clinical studies from the perspective of staff that carried
immediate responsibility for this work. This article also
adopts a specific focus on trust and extra-organisational
or national level factors that influence recruitment in
this context [37]. While the study took place in one clin-
ical research group in an Academic Health Science Centre
(AHSC), the theoretically generalised findings suggest the
significance of trust and national level factors. Given that
the factors we identify are by no means unique to this set-
ting, their perceived significance in this context suggests
they are likely to be relevant beyond the immediate
context, with wider implications for clinical research
policy in the UK and internationally.
Methods
The study was conducted in one clinical research groupa,
comprising several research teams, in a large inner-city
teaching hospital (acute trust) operating as a secondary
and tertiary referral centre. The hospital forms part of one
of six AHSCs in England and thus subscribes to a vision
of improved patient care, achieved through an NHS and
university partnership providing co-located research,
health education, and hospital services. The acute health
trust, was nationally acclaimed as an organisation “leading
the way in opportunities for patients to take part in clin-
ical research studies” [unpublished personal communica-
tion] and ranked in the national top 10 trusts for both the
quality of its clinical research and the number of hospital
patients involved in a clinical study [40]. Nevertheless,
based on regular monitoring of research recruitment
processes, local research and development managers con-
sidered that some clinical research groups were underper-
forming in relation to patient recruitment. The clinical
research group in this study (one of 12 groups organised
around different clinical research groupings in the Trust)fell into that category. During the year of the study (October
2011 to September 2012) its recruitment figures repre-
sented 3.5% of all patients recruited to research in the
Trust, and, in some instances, trials had been open for
one or two or more years without recruiting one suitable
research participant.
Following ethical overview and Research and Develop-
ment approval of the study by the acute hospital trust,
all research teams in the clinical research group were
notified of the objectives of the study. All research staff
invited to interview were again notified of the objectives
of the study and of the purpose of the interview. Each
potential interviewee was assured, in writing, of their
entitlement to anonymity and confidentiality. Written
consent was acquired from each interviewee and each
interviewee was reminded of their entitlement to with-
draw their data from the study database for up to three
months after their approval and return of their own
interview transcript.
The data were collected between December 2011 and
March 2012. Initially, purposive sampling of a range of
key staff in research teams (including chief and principal
researchers, research fellows, and support staff ) involved
in patient recruitment (n = 15) was initiated under the
guidance of local Research and Development leads. Due
to the limited or non-response of these staff, subsequent
snowball sampling was conducted on the advice of these
key staff. Sampling was intended to identify those staff
with greater experience or expertise in patient recruit-
ment work rather than to capture a numerically repre-
sentative sample of informants [41]. Overall, 15 staff
were invited to interview and 12 accepted the invitation.
The work roles of interviewees were: Trial Facilities
Manager (n = 1), Senior Research Nurse (n = 1), Clinical
Research Fellow (n = 2), and Research Nurse (n = 7).
Interviewees who were clinical researchers (n = 2) were
junior staff. The research nurses were also senior clini-
cians (clinical nurse specialists and/or research team
leads), however, their professional assistance or exchange
networks were defined by the Principal Investigators and
Chief Investigators on the studies that they were respon-
sible for recruiting to. All senior medical researchers
within the clinical research group were approached to
take part in this research. However, they deferred this
responsibility to nurses in their teams because they con-
sidered these staff responsible for patient recruitment.
Open-ended, one-to-one interviews were conducted with
all recruited staff and were guided by two broad research
questions. After establishing the work role, organisational
position, and work experience of each interviewee, inter-
viewees were asked their views on what factors either sup-
port or undermine the recruitment of patients into clinical
research in this research group and in the studies that they
were responsible for in particular. Eleven staff interviews
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between 40 and 70 minutes. One of these interviews was
conducted by telephone in a private office space and lasted
35 minutes. Interviews were conducted by one social scien-
tist (MA), who took short notes at the interview, typed up
longer notes immediately after the interview, and returned
these notes to interviewees within 24 hours for corrections
and additions before entering the anonymised transcripts
into a password-protected research database. Notes were
taken because the research was originally conducted as an
initial mapping exercise of issues in the clinical research
group. The interview schedule was limited to two core
questions: i) what factors support the recruitment of pa-
tients into clinical research here and ii) what factors inhibit
the recruitment of patients into clinical research here. The
interview schedule was deliberately open to allow for
interviewees own interpretation of factors. Probes were as
neutral as possible, e.g., ‘can you tell me a little bit more
about this?’ ‘Can you give me an example?’ One transcript
was not returned and so was removed from the database;
therefore, data were collected from 11 interviews. Returned
transcripts were organized and coded by MA using qualita-
tive data analysis software (NVivo9).
Following Ritchie, analysis of the data involved, first, a
descriptive examination “unpacking the content and
nature of a particular phenomenon or theme” [42] from
the data set and, second, an explanatory account that
involved “finding links and connections between two or
more phenomena” and that offered “a deeper under-
standing of the subject under review” [43] Thus, our
descriptive account summarised key limiting and
facilitating factors to patient recruitment, as noted by
the 11 interviewees, and our explanatory account sought
to understand these factors more systematically. MA
undertook the initial literature review, data analysis, and
write up, and CM checked this by reading a random
sample of the transcripts. LC added further literature
and supported MA with the final write-up. In addition
to adhering to established procedures to anonymise
interview transcripts, care was taken to ensure that
opinion given at interview could not be attributed to a
single individual to protect confidentiality.
Results and discussion
The researcher (MA) made approaches to all senior re-
searchers (Chief and Principal Investigators) responsible
for clinical studies that were ‘open’ (recruiting patients)
during that period. These studies ranged from emer-
gency and elective surgical procedures, drug studies,
remote monitoring and imagining, and exercise studies.
While our interviewees noted that different studies pre-
sented different challenges for recruitment, they all inde-
pendently volunteered the view that patient demographics
(particularly the challenges of recruiting elderly patientsinto research), anticipated costs and benefits (travel vs.
additional screening for example), and organisational
factors, were more significant to recruitment success than
the study itself.
Our descriptive account identified staff views on the
key factors that facilitated or undermined the recruit-
ment and retention of patients into research. The data
were also sorted and synthesized by a thematic chart to
summarise what staff discussed as the location of these
key factors (at patient, research-study, team, centre, or-
ganisation (trust), and extra-organisational levels). This
descriptive account of key factors, their organisational
location and their direction of influence, along with the
frequency of staff views on this, is summarised below.
Summary of staff views on key barriers and opportunities
for enhancing patient recruitment to clinical research and
their location
A. Competition for research participants
Study-Specific Factors
 Demands of study protocols (multiple exclusion
criteria) (11/11 interviewees)
 Clinical populations with complex chronic
disease (9/11)
 Competition with similar studies (8/11)
Centre-Specific Factors
 Presence of research teams requiring similar
clinical populations (7/11)
Trust-Specific Factors
 Competition between departments/divisions for
patients for own ‘portfolio’ studies (6/11)
Extra-Organisational Factors
 League tables and ‘pay for performance’ raises
competition for research subjects (5/11)
 Insufficient incentivisation of collaborative
referrals of patients into research (4/11)
B. Interface between clinical research and clinical care
Team-Specific Factors
 Proximity of team to clinical areas (build
research ‘presence’ and relationships) (7/11)
Trust-Specific Factors
 Non-research staff have limited resources to
undertake research tasks
 Value of clinical research not established/
recognised in clinical areas
Extra-Organisational Factors
 Limited resourcing to raise general awareness
of research to patients and the public (7/11)
C. Patient costs and benefits
Patient Specific Factors
 Need to protect older/more vulnerable patients
from excessive research burden (8/11)
Team-Specific Factors
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from participation (7/11)
 Relations of mutual reciprocity between staff
and participants (6/11)
Trust-Specific Factors
 Access to additional extra service resources for
participants (9/11)
D. The Clinical Research Team
 Commitment of research team to the particular
study (6/11)
 Availability of staff providing ‘personal benefit’
from participation (7/11), as above
 Relations of mutual reciprocity between staff and
participants (6/11), as above
 Proximity of team to clinical areas (build research
‘presence’ and relationships) (7/11), as above
 The status of recruitment work (if valued by
senior research clinicians) (10/11)
 Team approach to research design (including
recruitment feasibility) (6/11)
 Team approach to recruitment work (as simple
task or complex skill) (8/11)
Our explanatory account highlights and examines the
four key factors that influence recruitment success; these
are: i) competition for research participants; ii) intersec-
tions between clinical care and research; iii) patient costs
and benefits, and iv) the clinical research team. We found
that the nature of the clinical research team was perceived
by interviewees as a factor that could moderate several
other key factors.
Competition for research participants
The findings suggest that the focus on competition for
research participants at organisational (both centre and
trust) and national level can undermine the collabor-
ation necessary for ongoing patient recruitment to
different studies. Interviewees related that studies within
the research group often had similar, multiple, and
complex exclusion criteria. As the research centre was
located in a specialist (tertiary) acute hospital trust, the
patient population also had a high frequency of complex
clinical conditions and treatment histories which re-
duced the likelihood of research eligibility. Studies were
therefore recruiting from a highly limited population
while eligible participants had to be identified from
amongst the wider population. The difficulty of recruit-
ment to studies with multiple and complex exclusion
or inclusion criteria was clear from the anonymised
‘recruitment activity sheets’ kept for larger scale clinical
studies. Examination of these 2009 to 2011 records for
four major studies showed that an average of one in ten
patients was recruited after their consent to participate
in initial screening for research eligibility.Despite this challenging context for identifying eligible
participants, there were limited systems and processes
for the referral of potential research subjects between
different research teams within the centre and between
clinical departments. Interviewees related that research
teams (their own and others) were often protective of
their own ‘consent to be contacted’ patient databases.
For example, two extensive databases of patients willing
to be involved in future studies were kept within individ-
ual research teams and not shared more widely within
the centre or across the trust. Keeping ongoing and
exclusive relationships with ‘regulars’ was seen as an
important lever for recruiting patients to forthcoming
studies more quickly (so that studies met ‘by time and
target’ recruitment performance measures). Interviewees
perceived that sharing a database risked losing these
future research participants. For teams that had invested
their own time (including that spent applying for the
temporary funding of support staff ) in building and
maintaining a database that allowed them repeated
access to their own ‘regulars’ (patients who took part in
research on a serial basis and who were already on good
terms with them) the risks of collaboration in this
scenario were not always seen as worthwhile.
Some interviewees noted that the lack of collaboration
between research teams stemmed in part from the national
policy drive to double the numbers of patients in research
within 5 years. The attempt to achieve this, by publishing
league tables and providing quarterly benchmarks of
recruitment by trust, hospital, and centre, was considered
to undermine collaborative recruitment work between
organisations, research centres, and, in some cases,
research teams. Despite this, the competition for patients
in research did not affect all staff or research teams equally.
Some interviewees referred to informal and ongoing
‘knock for knock’ (reciprocal) arrangements that some-
times existed across teams, centres, and trusts. These
always involved more senior and longer established
clinical researchers. Senior researchers were further
advantaged by their increased ability to run better-
funded studies that could successfully attract more
patients by investments in high quality promotional
literature and regular study updates. By contrast, recruit-
ment was perceived as especially challenging for junior
researchers who lacked established reputations or
established and informal working relationships. In this
sense, the findings suggest that the national focus on
competition to drive research may undermine collabor-
ation in some contexts, particularly for less established
researchers.
The interface of clinical research and clinical care
The findings also highlight a perceived gap in national
provision for dealing with the additional burden that
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patients from acute and emergency care, research teams
often had to rely on non-research staff to identify potential
research participants for particular studies. Non-research
staff did not have protected or allocated time for recruit-
ing patients and interviewees perceived that busy ward
and outpatient staff easily forget about research work.
Experienced research nurses sought to address this locally
by relocating their offices or clinical rooms closer to
non-research clinical areas. Their closer proximity to ward
or outpatient staff and patients provided time for them to
build good relations for future potential referrals of pa-
tients and helped to remind and encourage busy clinicians
about research activity.
Similarly, our findings from staff interviews indicate
the inadequacy of national provision for dealing with
additional treatment costs, which could be associated
with research, or poor trust management of these costs.
Staff perceived that, without such payments being met
(and felt) on the appropriate front-lines of wards and
clinics, there was little to incentivise non-research staff
to work towards retaining patients in ongoing studies,
particularly when patients moved though different
organisations, services, and clinical areas over time. Notably,
research participants might become ineligible for contin-
ued study participation because of the demands of rou-
tine research tasks on ward and clinic time. Thus, ward
staff were known to be sometimes unable or unwilling
to accommodate the additional needs of research par-
ticipants (such as additional monitoring or screening
procedures, on-going sample collections, or overnight
admissions for pre-surgical research assessment). While
national agreements exist for organisational manage-
ment of ‘excess treatment costs’ [27], these arrange-
ments did not extend to ward levels. In this sense, while
national funding arrangements acknowledge the excess
treatment costs attributable to research, interviewees per-
ceived that these arrangements did not fully address them.
On this basis, most interviewees questioned recent ef-
forts, initiated at a national policy level [44], to promote
‘patient-led’ enquiries for improved research participa-
tion opportunities. Indeed, several nurses commented
on the perceived shortcomings of a recent national drive
for a patient-led research recruitment campaign. One
interviewee remarked: “It’s fine to say ‘It’s OK to Ask’…
but who do they think is going to be around to give the
answers?” (Interviewee 5). The majority of interviewees
viewed the challenge of improving recruitment as not
about raising general patient awareness and enthusiasm
about research but about the exercise of specialist clin-
ical knowledge and clinical relationships for identifying
those patients eligible for particular studies. Interviewees
justified their focus on research recruitment, rather than
research awareness work, in two ways, namely the needto protect patients from being rejected from studies for
which they were unsuitable candidates and the need to
protect their time from these unfruitful enquiries.
Patient costs and benefits
The findings suggest that some interviewees perceived
that systemic issues prevented them from addressing the
burden of research for patients, with implications for pa-
tient recruitment. Interviewees agreed that many patients
enter research with the desire to ‘give something back’.
However, some believed that in order to encourage pa-
tients to take part and to recognise their contribution to
research, patients should receive personal research benefit.
These staff sometimes sought to incentivise patients by
stressing indirect benefits of participation, available irre-
spective of randomisation. These included early screening,
additional clinical time, or quicker access to their consult-
ant by informal referral by a research nurse. However,
these staff felt limited in what they could formally offer to
research participants because of the regulatory demands
of ethics committees on research with patients. Patient in-
formation has to promise to offer no assurance of personal
benefit to patients in research in order to protect the
principle of informed, freely-given consent (without finan-
cial inducement). Staff felt that this emphasis on the lack
of personal benefit (particularly when patients as well as
funding bodies got personal benefit as clinical benefit)
acted as a barrier to recruiting patients who expected suf-
ficient compensation for, and recognition of, their time
and clinical labour. In this sense, established approaches
of national ethics committees were viewed by some inter-
viewees as a barrier to the appropriate incentivisation or
compensation of patients in research.
In keeping with previous research [5,7,15], the findings
also emphasise the importance of ensuring that research is
not perceived by clinicians to place an excessive burden
on patients or to compromise their safety, and that re-
search has clear benefits for patients. More experienced
staff noted their professional responsibility to assess and
manage the cost/benefits of research participation for
patients through the course of a study. It was generally
agreed (by research fellows and nurses) that research
nurses were better positioned to assess the cost/benefits
of research compared to senior clinical academics (who
were less involved in the day-to-day running of studies) or
patients themselves (who had to rely on narrow or gener-
alised patient information literature). These research
nurses were often more critical of the excessive research
burden that they perceived some on-going studies placed
on patients. In addition, many staff privately questioned
the ethical justification for some on-going AHSC studies,
particularly long-running studies with future results that
had already been overtaken by changes in (as yet un-
proven) clinical practice. Such studies often ‘lagged’ in
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study, particularly when faced with opposition from non-
research clinical colleagues. The findings also suggest that
staff perceived that schedules of return hospital visits,
home monitoring requirements, lifestyle changes, or treat-
ment regimens often created unexplained or unanticipated
burdens of research participation that were too onerous
for the elderly or the very sick. However, other staff noted
the dangers of anticipating that the elderly and vulnerable
should be excluded from a choice to participate in studies.
In this sense, the findings suggest the criticality of
ensuring that research, funded by national bodies on the
basis of the important contribution that it will make and
its ethical justifiability, is perceived in the same way by
those on the ground. Our findings suggest that in some
cases there is a disconnect between the national level
and the ‘sharp end’ in this regard, with implications for
recruitment and retention of patients to research.
The clinical research team
The normative organisation of clinical research teams, in
terms of professional management hierarchies that sep-
arate research recruitment work from research leader-
ship, was also found to influence patient recruitment.
The research nurses and junior researchers interviewed
related that, in their experience, senior clinical researchers
and particularly medical or surgical consultants were more
successful at recruiting patients than all other staff. In-
terviewees considered that this was either because patients
felt less able to refuse their invitations or felt more
confident of research promoted by them. In addition, as
noted above, senior staff had established networks which
they could use to recruit patients from across clinical
areas. However, in this clinical research group recruitment
to research was perceived as lowly work in contrast to
other research activities. Thus, senior staff rarely recruited
patients to studies themselves. Indeed, as our description
of study methods above suggests, senior researchers
declined our invitation to be interviewed on patient
recruitment work because they did not consider this to
be their work responsibility. Thus, clinicians with less au-
thority (who, interviewees noted, sometimes have limited
insight into the nature and risks of research study) were
left to explain the value of participation to patients.
Our interviewees felt that this distancing of research
leaders from recruitment work negatively affected recruit-
ment. Most interviewees noted that for a study to be suc-
cessful, the whole research team needed to be involved in
study design, progress monitoring, and review. Inter-
viewees suggested that a situation of shared knowledge,
interest, and investment in a study enhanced successful
patient recruitment in itself. In the words of one research
nurse, “successful research relies on people caring about
the study… about them really believing in it” (Interviewee5). In this sense, an overly rigorous or exclusive division of
labour within a research team may have a negative effect
on recruitment. In addition, it is notable that in some
other clinical research groups within the trust (and par-
ticularly in those more successful in recruiting patients in
research), senior medical and nursing clinicians actively
recruited patients into the studies where recruitment was
most difficult and mentored junior researchers in recruit-
ment skills. Thus, the traditional division of labour was
not insurmountable but required a levelling of hierarchies
to combine research leadership with research recruitment.
Conclusions
In this study, we examined, from the perspective of staff
responsible for recruiting patients into clinical research,
the multi-levelled and complex nature of factors that
affected work at the ‘sharp end’ of practice. The research
took a small scale and in-depth approach, investigating
work in one clinical research group located in a research
centre with an exemplary national reputation.
In some respects, the findings substantiate those of pre-
vious research, outlined in the introduction to this article.
This includes the finding that, in terms of procedural is-
sues for recruitment, inter-professional cooperation is im-
portant for the identification, recruitment, and retention
of patients [3,7,37]. Our findings add weight to previous
research, which suggests that staff views on the balance of
costs against and benefits to patients in research is vital to
ensure successful recruitment work [5,7]. It is noted that
these perceptions may be influenced by how the research
is communicated to and understood within staff teams
[14,22,24,31], but this was not a focus of our study, which
did not observe trial meetings. Further, our findings con-
cur with previous research which has found that strain on
clinical resources and time is detrimental to research
[5,7,25,33].
At the same time, rather than necessarily contradicting
the findings of previous research, this article draws atten-
tion to previously overlooked issues by highlighting the
need to consider how ‘high level’ factors and processes get
played out ‘on the ground’, often in unpredicted ways. Our
findings suggest that cooperation between professionals
may be discouraged by the national drive to increase re-
cruitment through competition, benchmarking, and ‘pay-
ment by [recruitment] results’. While cooperation exists,
this may be despite rather than because of such national
initiatives. More junior staff, who have not yet built a
reputation, are, in particular, not helped by the focus on
competition. We suggest that further research is required
to extend our understanding of the potential for auditing
systems to impact recruitment in unintended ways.
In the same vein, our findings highlight that, while
national funding agreements acknowledge the extra
treatment and time costs attributable to research, the
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contributions are either insufficient (and so require a
closer factoring into research design and funding appli-
cations) or that these contributions are not reaching the
relevant clinical areas. In either case, the insufficient
contribution to the research work conducted in wards
and clinics leads to strain between clinical and clinical
research work and resourcing priorities, with a deleteri-
ous impact on recruitment.
Maintaining the focus on previously overlooked ‘high
level’ factors, our findings highlight that some recruiters
to research perceive that established ethical regulatory
expectations – that prevent researchers from promising
direct benefits to patients in research – are a barrier
to being able to offer appropriate compensation and
encouragement for patients offering time and clinical
labour. These findings cannot provide any estimate of
the prevalence of this view and, regardless, ethical stand-
points are not a simple matter of democratic decision
making. However, ethical standards are not static. As so-
cial constructs, they change over time. In this regard we
suggest that the voices of those undertaking recruitment
be heard as part of a wider critical review of the ethical
requirement that patients should not receive direct
benefit for participation in publically funded research.
Finally, the findings suggest that the established hierarch-
ies of research work, with the lowly work of recruitment
and retention undertaken by more junior professionals
and, increasingly, non-professionals, operates as a barrier
to successful work. Our interviewees noted the relative
success of some senior research clinicians in recruiting
patients into studies either because of their authority,
knowledge of the study, or communication skills. More sig-
nificant, the value of clinical research team leadership that
included a whole team approach to patients in research
was noted by our interviewees as an especially successful
way of enhancing patient recruitment and retention.
Our study is limited in several respects. Our aim was
not to examine all issues impacting recruitment. Instead,
we sought to examine how staff who recruited patients
understood and explained the barriers and opportunities
to this work. We examined how these front-line activ-
ities are affected by policy drivers operating at national,
organisational (hospital trust), and extra-organisational
levels. We note that the factors identified by our inter-
viewees are inevitably influenced by their subject posi-
tionality (for example, interviewees might emphasise
systemic factors rather than focus on their own or their
colleagues shortcomings). Nonetheless, the aim of this
study was not to present an objective assessment of bar-
riers affecting research, but to examine the subjective ac-
counts of those working at the frontline of recruitment.
We argue that the subjectivity of these accounts is what
makes them valuable since the ways that those at thefront-line of recruitment perceive their work is likely to
affect their behaviour.
In terms of the research scope, it should also be noted
that only the views of nominated staff representatives
(those front-line and junior staff with a recruitment work)
from one clinical research group in an AHSC were
examined. The study was further limited to recruitment to
biomedical research (and particularly clinical trials) in an
acute hospital setting, rather than to health research in
general. Further research in other contexts is required to
examine the particular barriers and opportunities to
patient recruitment to health research in other settings.
Moreover, the views of non-research clinicians and pa-
tients/study participants themselves were not addressed in
our study, which focused explicitly on the views of staff
recruiting and retaining patients. Clinical research, in-
cluding recruitment activity, is co-constructed and examin-
ation of these voices is necessary for further understanding
of the issues raised in our study.
Finally, the study is limited by the small sample size,
although the findings are not invalidated by this since
qualitative research seeks theoretical rather than statis-
tical generalizability [41]. However, further themes may
have arisen in a larger and more diverse sample. We
argue that the factors identified in this study are by no
means unique to this setting and so are generalizable
beyond this study. Their perceived significance in this
context suggests that they are potentially perceived and
experienced in similar ways in other settings, with impli-
cations for recruitment and retention to research.
Endnote
a This is common medical field, but in order to protect
participants’ anonymity we have not named the specific
clinical area.
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